Service Quote Request
Please fill out the form below with your detailed inquiry.
Stable cell lines are engineered cells that maintain a specific genetic modification over many generations. Unlike transient transfection, where gene expression gradually decreases, stable cells provide consistent and long-term expression or knockdown of a target gene.
Stable cells are created by integrating a gene, shRNA, gRNA, reporter, or selection cassette into the host cell genome. Once integrated and selected, the modified cells can be expanded and maintained as a stable population or isolated as single-cell clones.
Stable cell lines are widely used for long-term gene overexpression, shRNA-mediated gene knockdown, CRISPR/Cas9 screening or gene editing, reporter assay development, protein production, drug screening, and functional studies requiring reproducible expression.
Lentiviral vectors are commonly used because they efficiently transduce both dividing and non-dividing cells and integrate into the host genome. This makes them highly suitable for generating stable cell pools or clonal cell lines.
After transduction, antibiotic selection is often used to enrich successfully modified cells. Common markers include puromycin (fast and strong selection), blasticidin (effective in many mammalian cells), hygromycin (suitable for longer selection periods), and neomycin/G418 (widely used but often slower). A kill curve is recommended to determine optimal concentrations.
Stable pools are faster to generate and preserve population diversity, making them useful for screening. Single-cell clones provide more uniform expression and are preferred when consistency and reproducibility are required.
Successful stable cell line development depends on factors such as cell type, vector design, promoter choice, selection marker, transduction efficiency, and clone screening strategy. Some primary or sensitive cells may not tolerate antibiotic selection well.
Stable cell line development is a foundational technique in modern molecular and cellular biology. By combining lentiviral delivery, antibiotic selection, and clone validation, researchers can generate reliable cell models for long-term functional studies, assay development, and therapeutic discovery.